Stanford School of Medicine Career Management Series
Naturejobs and Stanford University School of Medicine Career Center (SoMCC) have collaborated to
bring you the SoMCC "Industry Insights" seminar series. This series provides a forum for leaders in business and academia to share first-hand experiences and perspectives on the trends and forces shaping the biosciences enterprise informed by their respective vantage points. In so doing the series offers unique visibility into the diverse settings where biomedical professionals are engaging their skills and forming careers.
Industry Insights
How should we be developing drugs in the 21st century?Date published: 13 July 2006
- Chapter 1: Introduction and Overview
- Michael Alvarez introduces Hal Barron, MD.
- Chapter 2: Research & Development
- Dr, Barron discusses R&D spending and success rates.
- Chapter 3: Biomarkers
- Dr. Barron talks about the importance of biomarkers.
- Chapter 4: Developing Drugs in the 21st Century
- Dr. Barron explores "how should we be developing drugs in the 21st century."
- Chapter 5: Drugs Are Not Safe
- Dr. Barron illustrates why "drugs are not safe."
- Chapter 6: Conclusion & Q&A
- Dr. Barron concludes his presentation and answers questions posed by audience members.
- Chapter 7: Q&A Part II
- Dr. Barron concludes Q&A.
